serine/threonine Kinase 17b (STK17B) Peptide
STK17B
Reactivity: Human, Cow, Mouse, Rat
Host: Synthetic
BP
-
- Target See all DRAK2 (STK17B) products
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Origin
- Human, Cow, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-STK17B Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Synonyms
- zgc:65989 Peptide, STK17B Peptide, DRAK2 Peptide, Drak2 Peptide, 3110009A03Rik Peptide, AI120141 Peptide, serine/threonine kinase 17b (apoptosis-inducing) Peptide, serine/threonine kinase 17b Peptide, stk17b Peptide, STK17B Peptide, Stk17b Peptide
- Background
- DRAK2, Serine/threonine-protein kinase 17B, DAP kinase-related apoptosis-inducing protein kinase 2
- Gene ID
- 9262, 98267, 170904
- UniProt
- O94768, Q8BG48, Q91XS8
-
You are here:
